Chandra, Shruti http://orcid.org/0000-0002-2634-9775
Gurudas, Sarega
Burton, Benjamin J. L. http://orcid.org/0000-0001-9579-9078
Menon, Geeta
Pearce, Ian
Mckibbin, Martin http://orcid.org/0000-0003-4388-243X
Kotagiri, Ajay
Talks, James
Grabowska, Anna http://orcid.org/0000-0002-3053-2142
Ghanchi, Faruque http://orcid.org/0000-0002-4448-8162
Gale, Richard
Giani, Andrea
Chong, Victor http://orcid.org/0000-0002-7693-522X
Yamaguchi, Taffeta Ching Ning
Pal, Bishwanath
Thottarath, Sridevi
Pakeer, Raheeba Muhamed
Chandak, Swati
Montesel, Andrea
Sivaprasad, Sobha
Article History
Received: 8 April 2023
Revised: 4 September 2023
Accepted: 21 September 2023
First Online: 18 October 2023
Competing interests
: SS received consultancy fees from Bayer, Allergan, Novartis Pharma AG, Roche, Boehringer Ingelheim, Optos, Apellis, Oxurion, Oculis and Heidelberg Engineering. VC is an employee of Janssen R&D and previously of Boehringer Ingelheim. AGi is an employee of Boehringer Ingelheim. TCNY is an employee of Boehringer Ingelheim. BB is in the advisory board and received international conference attendance sponsored by Novartis and Bayer; GM has conducted consultancy-advisory boards for Novartis, Bayer and Allergan, received educational travel grants from Novartis, Bayer, Allergan; IP has received lecture fees from Allergan, Bayer, Heidelberg and Novartis, consultancy fees from Allergan, Alimera, Bayer and Novartis and travel fees from Allergan, Bayer and Novartis. FG has received honorarium for consultancy-advisory boards from Alimera, Allergan, Bayer, Novartis, Oxford BioElectronics, Roche; educational travel grants from Allergan, Bayer, Novartis. MM has received lecture and advisory board honoraria from Bayer and Novartis and an educational travel grant from Bayer. RG has conducted consultancy-advisory boards for Novartis, Bayer and Allergan, Alimera, Santen, received educational travel grants from Novartis, Bayer, Allergan, Heidelberg Engineering. JT is a consultant for Bayer and Novartis, received grant support from Bayer, Novartis and Heidelberg Engineering, and is involved in research for Allergan, Roche, Bayer, Novartis and Boehringer Ingelheim. AK received travel support from Novartis, Bayer, and Allergan, and speaker fees from Allergan and Bayer. Bishwanath Pal received travel support and received advisory boards honoraria from Novartis and Bayer. ShC, SG, ST, RMP, SC and AM have no financial disclosures. SS, FG, and ShC are members of the <i>Eye</i> editorial board.